Abstract
In this work an improved stable isotope labeling protocol for nucleic acids is introduced. The novel building blocks eliminate/minimize homonuclear 13C and 1H scalar couplings thus allowing proton relaxation dispersion (RD) experiments to report accurately on the chemical exchange of nucleic acids. Using site‐specific 2H and 13C labeling, spin topologies are introduced into DNA and RNA that make 1H relaxation dispersion experiments applicable in a straightforward manner. The novel RNA/DNA building blocks were successfully incorporated into two nucleic acids. The A‐site RNA was previously shown to undergo a two site exchange process in the micro‐ to millisecond time regime. Using proton relaxation dispersion experiments the exchange parameters determined earlier could be recapitulated, thus validating the proposed approach. We further investigated the dynamics of the cTAR DNA, a DNA transcript that is involved in the viral replication cycle of HIV‐1. Again, an exchange process could be characterized and quantified. This shows the general applicablility of the novel labeling scheme for 1H RD experiments of nucleic acids.
Keywords: DNA, NMR spectroscopy, proton relaxation dispersion, RNA, stable isotope labeling
Conformational heterogeneity expands the functional repertoire of nucleic acids.1 These transitions between structurally different conformational states add an additional layer of functional adaptability of nucleic acids. NMR spectroscopy has proven to be very well suited to investigate such transitions and to detected and characterize so called excited states.1e, 2 These low populated sub‐states represent high free‐energy conformations, that are speculated to be involved in important processes, such as ligand binding, protein–nucleic acid recognition or catalysis by ribozymes. Several methods, like chemical exchange saturation transfer (CEST), R 1ρ and CPMG relaxation dispersion experiments, have been recently applied to nucleic acids and have proven to be suitable to characterize kinetic, thermodynamic, and structural parameters of the exchange process between the ground and excited state.3 Noteworthy, a 1H CEST experiment was recently introduced by Dayie and co‐workers. With the aid of this experiment proton chemical shifts of the S‐adenosylmethionine (SAM) II riboswitch excited state could be determined. In their work a slow exchange process (k ex≈30 s−1) was found with the high energy state conformation resembling the SAM bound state supporting a conformational selection mechanism for this aptamer. The approach also benefited from site‐specific 13C‐1′‐, 13C‐6‐labeling resulting in the absence of strong 1 J CC‐couplings.3h
Typically, experiments to address functional dynamics obtain the parameters from X‐spin relaxation data (X being 13C or 15N). It would be very beneficial to adapt NMR methods and isotope labeling protocols for nucleic acids to apply RD experiments on proton spins, as the experimental constraints are less stringent for 1H as discussed below. This method has been successfully applied to proteins only and has provided insights into for example, functional dynamics during protein folding and enzyme catalysis.4 Several advantages make 1H RD experiments very attractive for the characterization of excited states. For example, reduced sample heating during the CPMG train, a shorter 180° pulse length, and a wider range of the effective CPMG field strengths (up to 5 kHz) can extend the CPMG method to address transient states with shorter lifetimes. Even more important, the 1H RD experiment would give access to excited‐state proton chemical shifts. Recently, 1H chemical shifts were shown to be very sensitive reporters of nucleic acid tertiary structure and were used for the de novo 3D structure prediction of RNA.5 Thus, 1H RD experiments create the opportunity to use excited state proton chemical shifts to obtain insights into structural details of the low populated high‐energy conformation.
One mandatory prerequisite to apply the 1H RD NMR experiment is the absence of large homonuclear 1H–1H scalar couplings. In nucleic acids the low proton density in the nucleobase moieties facilitates the applicability of the experiment. For example, purine nucleobases offer per se an ideal spin topology for proton RD experiments. The absence of nearby protons makes the 1H–C8 spin pair of adenine and guanine ideally suited for 1H RD experiments. For the simple and selective read‐out of the H8 resonance, 13C labeling of position 8 in purines would be advantageous. Thus, the synthetic access to 8‐13C‐purine DNA and RNA phosphoramidites and the incorporation into a nucleic acid via the solid phase synthesis approach (Figure 1 a and b) allows for conducting 1H relaxation dispersion experiments in nucleic acids. Experimental details on the synthesis of 8‐13C‐RNA purine amidites can be found in the supporting information. The synthesis of the 8‐13C‐purine DNA amidites will be published elsewhere.
We earlier reported on the synthesis of 6‐13C‐pyrimidine RNA phosphoramidites.3d The uracil and cytosine nucleobases do not offer an appropriate spin topology due to presence of the H5/H6 scalar coupling (3 J H5/H6≈8 Hz). This issue can be circumvented by the inclusion of a selective deuteration step to replace the proton at position 5 by deuterium yielding 6‐13C‐5‐d‐pyrimidine building blocks with a very small D5/H6 scalar coupling constant (3 J D5/H6≈1 Hz) making 1H RD experiments feasible even in the absence of deuterium decoupling (Figure 1 c and d). The synthesis of the 6‐13C‐pyrimidine RNA building blocks was described in detail earlier.3d The additional deuteration step is now included in the supporting information. The synthesis of the 6‐13C‐5‐d‐2′‐deoxycytidine amidite will be reported elsewhere.
Using the novel building blocks 13 nucleotides of the 27 nt A‐site mimic were replaced with their 13C/2H labeled counterparts (Figure 2 a). The successful incorporation was confirmed by mass spectrometry (Figure S1 a in the Supporting Information) and NMR spectroscopy (Figure 2 b).
A detailed investigation using 13C R1ρ relaxation dispersion NMR was recently conducted on this RNA.3a The RNA is involved in the selection process of cognate and near‐cognate tRNAs in the ribosome. The residues A92 an A93 play an important role in that recognition step, as they stabilize the cognate tRNA/mRNA complex while in a flipped out state. A two state equilibrium between two secondary structures 1 a and 1 b—the ground state 1 a being the functional state, the excited state 1 b being non‐functional with A92 and 93 sequestered in non‐canonical base pairs—with an exchange rate constant of 4 kHz at 25 °C and an excited state population of 2.5 % was found. We choose this system as it is ideally suited to validate the novel isotope labeling scheme and because of its applicability to conduct proton relaxation dispersion NMR experiments. The stable isotope labeled residues were introduced around the A8–A92–A93 bulge and in the UUCG tetraloop. The bulge sequence partition is restructured in the excited state 1 b leading to observable relaxation dispersion profiles so far shown for carbon‐13, whereas the UUCG loop residues are expected to show flat dispersion profiles. Based on a published proton relaxation dispersion experiment for 15NH spin pairs in per‐deuterated proteins we could establish a simple pulse scheme as the optimized 13C–1H spin topology in both, purine and pyrimidine nucleobases, results in the absence of large homonuclear scalar couplings and thus making the application of the 1H dispersion experiment very straightforward.4a,4d, 6
The pulse scheme is included in the supporting information section and is available upon request. Proton relaxation dispersion experiments were conducted at 500 and 600 MHz resonance frequencies for purines and pyrimidines and at 800 MHz for an 8‐13C‐adenosine labeled sample only. A selection of experimentally obtained non‐flat proton relaxation dispersion profiles is shown for the residues C7, A10, A93, G94 and U95 (Figure 2 c). Other residues, which could potentially sense the exchange process between the alternative secondary structures—such as residues U6, A8 and U90—gave no statistically significant relaxation dispersion profiles, very likely due to small chemical shift differences between ground and excited state. The loop U residues U14 and U15 exhibited flat dispersion profiles as expected. The parameters obtained—an overall exchange rate constant k ex of 1880±140 s−1 and an excited state population p B of 4.06±1.28 % at 12 °C—from fitting the 1H RD profiles of C7, C9, A10, A93, G94 and U95 are in good agreement with the previously reported data from 13C relaxation experiments (k ex=4 kHz, p B=2.5 % at 25 °C) validating the 1H RD approach to study milli‐ to microsecond dynamics in RNA. A summary of the exchange parameters obtained from the 1H relaxation data is given below (Table 1).5c We also compared the obtained chemical shift differences from the proton RD experiment with reference data for the excited state 2 b with mutants mimicking the excited state (ΔU95 and N3MU95 mutants). A fairly good correlation was observed indicating that the proposed base pair reshuffling process is recapitulated via the proton RD experiment (Table S1 in the Supporting Information).
Table 1.
Residue | k ex [s−1][a] | p B [%][b] | |Δ |[ppm][c] | |
---|---|---|---|---|
A‐site RNA 1 a/b 285 K | C7 C9 A10 A92 A93 G94 U95 | 1880±140 | 4.06±1.28 | 0.24±0.07 0.15±0.08 0.22±0.05 0.14±0.07 0.24±0.05 0.34±0.07 0.29±0.06 |
cTAR DNA 2 a/b 298 K | G4 A5 C19 G20 A21 C22 C23 | 525±59 | 1.0±0.1 | 0.25±0.02 0.49±0.03 0.22±0.01 0.20±0.02 0.56±0.03 0.34±0.02 0.24±0.01 |
[a] Exchange rate constant and [b] population from global fit of relaxation dispersion data of residues with significant relaxation dispersion at all magnetic fields. [c] Residue‐specific chemical shift difference between ground and excited state. Details on the fitting procedure are given in the Supporting Information.
We then turned our attention to the selective labeling of DNA and to study excited states in DNA using the 1H RD experiment. We picked the cTAR DNA (MAL isolate) 2 a/2 b as a target (Figure 3 a).7 This DNA is involved in the viral replication cycle of the HIV‐1 and fulfils a priming function via hybridization to the viral genomic RNA. The nucleocapsid protein NCp 7 interacts with the cTAR element and the 55 amino acid polypeptide acts as a nucleic acid chaperone facilitating the DNA/RNA hybridization step.8 The DNA comprises 26 nucleotides and is supposed to fold into a hairpin‐bulge conformation (Figure 3 a). The previously proposed secondary structure 2 b—an extended hairpin with an internal bulge—represents a minor conformation under the NMR conditions at ambient temperature, as the lower stem does not exhibit any observable imino proton resonances. The upper stem is formed as the signals from hydrogen bonded protons can be observed. These imino proton assignments have been published earlier.7a The assignment was further supported by selective 15N‐deoxy guanosine labeling (Figure S2 a and b in the Supporting Information). Thus, the major fold 2 a was assigned to a short hairpin structure with 5′‐ and 3′‐dangling ends. We replaced 10 residues by their 13C/2H labeled counterparts and again the isotope labeling pattern was confirmed by NMR and MS (Figure 3 b and Figure S1 b in the Supporting Information). At this point we speculated that the fully folded state 2 b is only sparsely populated. To test this hypothesis we used the proton relaxation dispersion experiment to probe milli‐ and microsecond dynamics in this DNA. We again obtained high quality data and found an exchange process for residues G4, A5, G6, C19, G20, A21, C22 and C23, which cluster in the bulge and the lower stem region and at the lower end of the upper stem (Figure 3 c). A global fit of the proton dispersion data gave an excited state population p B of 1.0±0.1 % and an exchange rate k ex of ca. 525±59 s−1. Again, a summary of the exchange parameters obtained from the 1H relaxation data is given below (Table 1). The dispersion data clearly confirms an exchange process located in the 5′‐ and 3′‐dangling ends. The excited state chemical shifts correlate well with standard B‐form DNA H6/H8 resonance frequencies inline with state 2 a being more structured than ground state 1 a (Table S1 in the Supporting Information). Using the previously reported mutate and chemical shift fingerprint (MCSF) approach we currently investigate the secondary structure of the cTAR DNA excited state in more detail and the influence of the nucleocapsid protein NCp 7 on the exchange process.3a
Taken together, we have introduced a stable isotope labeling protocol for nucleic acids that allows for the first time the extraction of accurate chemical exchange parameters from proton relaxation dispersion experiments. The dispersion experiment can be used to characterize dynamic processes occurring at the ms‐ to μs‐time scale. Furthermore, it has been recently shown that proton chemical shifts are sensitive reporters of RNA tertiary structure and that the 1H chemical shift values can be used as input parameters for the de novo high resolution structure prediction using CS Rosetta RNA.5c Our NMR based approach yields absolute value proton chemical shift differences between the ground and the excited state. Combining this shift difference data from the 1H dispersion profiles with NMR experiments that allow the determination of the sign of the chemical shift difference opens the possibility to reconstruct the nucleobase's proton spectrum of the excited state.9 A method to utilize this sparse proton chemical shift data together with residual dipolar couplings (RDCs) in the structure elucidation of excited states is currently developed in our laboratories.
We also plan to transfer the revised stable isotope labeling pattern to ribonucleotide triphosphates, which can be used in the enzymatic production of RNA.3i, 10 This will significantly contribute to the dissemination of the presented approach, as T7 RNA polymerase in vitro transcription is the most widespread methodology to produce stable isotope modified RNA for NMR spectroscopy.
Supporting information
Acknowledgements
C.K. thanks Thomas Mueller for the acquisition of mass spectra of the phosphoramidites and D.F.H. acknowledges the MRC Biomedical NMR Centre for access to the 800 MHz NMR spectrometer. Funding by the Austrian Science Fund FWF (P26550 and P28725 to C.K., P26849 to M.T.) and support from the Biotechnology and Biological Sciences Research Council UK (D.F.H.) are acknowledged.
M. A. Juen, C. H. Wunderlich, F. Nußbaumer, M. Tollinger, G. Kontaxis, R. Konrat, D. F. Hansen, C. Kreutz, Angew. Chem. Int. Ed. 2016, 55, 12008.
Contributor Information
Dr. D. Flemming Hansen, Email: d.hansen@ucl.ac.uk.
Dr. Christoph Kreutz, Email: christoph.kreutz@uibk.ac.at.
References
- 1.
- 1a. Al-Hashimi H. M., Walter N. G., Curr. Opin. Struct. Biol. 2008, 18, 321–329; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 1b. Dethoff E. A., Chugh J., Mustoe A. M., Al-Hashimi H. M., Nature 2012, 482, 322–330; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 1c. Haller A., Soulière M. F., Micura R., Acc. Chem. Res. 2011, 44, 1339–1348; [DOI] [PubMed] [Google Scholar]
- 1d. Mustoe A. M., Brooks C. L., Al-Hashimi H. M., Annu. Rev. Biochem. 2014, 83, 441–466; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 1e. Zhao B., Zhang Q., Curr. Opin. Struct. Biol. 2015, 30, 134–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.
- 2a. Mittermaier A. K., Kay L. E., Trends Biochem. Sci. 2009, 34, 601–611; [DOI] [PubMed] [Google Scholar]
- 2b. A. G. Palmer III , J. Magn. Reson. 2014, 241, 3–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.
- 3a. Dethoff E. A., Petzold K., Chugh J., Casiano-Negroni A., Al-Hashimi H. M., Nature 2012, 491, 724–728; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3b. Kimsey I. J., Petzold K., Sathyamoorthy B., Stein Z. W., Al-Hashimi H. M., Nature 2015, 519, 315–320; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3c. Nikolova E. N., Kim E., Wise A. A., O'Brien P. J., Andricioaei I., Al-Hashimi H. M., Nature 2011, 470, 498–502; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3d. Wunderlich C. H., Spitzer R., Santner T., Fauster K., Tollinger M., Kreutz C., J. Am. Chem. Soc. 2012, 134, 7558–7569; [DOI] [PubMed] [Google Scholar]
- 3e. Xue Y., Kellogg D., Kimsey I. J., Sathyamoorthy B., Stein Z. W., McBrairty M., Al-Hashimi H. M. in Methods in Enzymology, Vol. 558 (Eds.: A. W. Sarah H. T. A. Frédéric), Academic Press, New York, 2015, pp. 39–73; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3f. Zhao B., Hansen A. L., Zhang Q., J. Am. Chem. Soc. 2014, 136, 20–23; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3g. Zhao B., Zhang Q., J. Am. Chem. Soc. 2015, 137, 13480–13483; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3h. Chen B., LeBlanc R., Dayie T. K., Angew. Chem. Int. Ed. 2016, 55, 2724–2727; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2016, 128, 2774–2777; [Google Scholar]
- 3i. Longhini A. P., LeBlanc R. M., Becette O., Salguero C., Wunderlich C. H., Johnson B. A., D'Souza V. M., Kreutz C., Dayie T. K., Nucleic Acids Res. 2016, 44, e52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.
- 4a. Hansen A. L., Lundström P., Velyvis A., Kay L. E., J. Am. Chem. Soc. 2012, 134, 3178–3189; [DOI] [PubMed] [Google Scholar]
- 4b. Kern D., Eisenmesser E. Z., Wolf-Watz M. in Methods in Enzymology, Vol. 394, Academic Press, New York, 2005, pp. 507–524; [DOI] [PubMed] [Google Scholar]
- 4c. Otten R., Villali J., Kern D., Mulder F. A. A., J. Am. Chem. Soc. 2010, 132, 17004–17014; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4d. Vallurupalli P., Hansen D. F., Lundström P., Kay L., J. Biomol. NMR 2009, 45, 45–55. [DOI] [PubMed] [Google Scholar]
- 5.
- 5a. Frank A. T., Bae S.-H., Stelzer A. C., J. Phys. Chem. B 2013, 117, 13497–13506; [DOI] [PubMed] [Google Scholar]
- 5b. Frank A. T., Horowitz S., Andricioaei I., Al-Hashimi H. M., J. Phys. Chem. B 2013, 117, 2045–2052; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5c. Sripakdeevong P., Cevec M., Chang A. T., Erat M. C., Ziegeler M., Zhao Q., Fox G. E., Gao X., Kennedy S. D., Kierzek R., Nikonowicz E. P., Schwalbe H., Sigel R. K. O., Turner D. H., Das R., Nat. Methods 2014, 11, 413–416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.
- 6a. Weininger U., Liu Z., McIntyre D. D., Vogel H. J., Akke M., J. Am. Chem. Soc. 2012, 134, 18562–18565; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6b. Ishima R., Torchia D. A., J. Biomol. NMR 2003, 25, 243–248. [DOI] [PubMed] [Google Scholar]
- 7.
- 7a. Zargarian L., Kanevsky I., Bazzi A., Boynard J., Chaminade F., Fossé P., Mauffret O., Nucleic Acids Res. 2009, 37, 4043–4054; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7b. Bazzi A., Zargarian L., Chaminade F., De Rocquigny H., René B., Mély Y., Fossé P., Mauffret O., PLoS ONE 2012, 7, e38905; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7c. Bazzi A., Zargarian L., Chaminade F., Boudier C., De Rocquigny H., René B., Mély Y., Fossé P., Mauffret O., Nucleic Acids Res. 2011, 39, 3903–3916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.
- 8a. Godet J., Kenfack C., Przybilla F., Richert L., Duportail G., Mély Y., Nucleic Acids Res. 2013, 41, 5036–5048; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8b. Godet J., de Rocquigny H., Raja C., Glasser N., Ficheux D., Darlix J.-L., Mély Y., J. Mol. Biol. 2006, 356, 1180–1192; [DOI] [PubMed] [Google Scholar]
- 8c. Beltz H., Piémont E., Schaub E., Ficheux D., Roques B., Darlix J.-L., Mély Y., J. Mol. Biol. 2004, 338, 711–723; [DOI] [PubMed] [Google Scholar]
- 8d. Godet J., Mély Y., RNA Biol. 2010, 7, 687–699. [DOI] [PubMed] [Google Scholar]
- 9.
- 9a. Auer R., Neudecker P., Muhandiram D. R., Lundström P., Hansen D. F., Konrat R., Kay L. E., J. Am. Chem. Soc. 2009, 131, 10832–10833; [DOI] [PubMed] [Google Scholar]
- 9b. Bouvignies G., Korzhnev D., Neudecker P., Hansen D. F., Cordes M. J., Kay L., J. Biomol. NMR 2010, 47, 135–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.
- 10a. Alvarado L. J., LeBlanc R. M., Longhini A. P., Keane S. C., Jain N., Yildiz Z. F., Tolbert B. S., D'Souza V. M., Summers M. F., Kreutz C., Dayie T. K., ChemBioChem 2014, 15, 1573–1577; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10b. Alvarado L. J., Longhini A. P., LeBlanc R. M., Chen B., Kreutz C., Dayie T. K. in Methods in Enzymology, Vol. 549 (Ed.: H. B.-A. Donald), Academic Press, New York, 2014, pp. 133–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.